Company intelligence / Profile preview
TwoStep Therapeutics
San Carlos, California, United Statestwosteptx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
TwoStep Therapeutics has demonstrated in vivo proof of concept for its multi-targeted agent using various therapeutic payloads and fusion proteins in academic labs and within the Stanford Innovative Medicines Accelerator. The lead program, a tumor-targeted drug conjugate, has shown outstanding preclinical efficacy and safety. A radiopharmaceutical program is also advancing through preclinical development
- Therapeutic areas
- Oncology
- Modalities
- Peptide-drug conjugatesRadiopharmaceuticals (radioligand therapy)Immunotherapy agents (fusion proteins)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Johnson & Johnson Innovation – JLABS residency at MBC BioLabs site
Beyond the preview
Go deeper on TwoStep Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TwoStep Therapeutics.